Advanced Enzyme Technologies Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
- August 7, 2026
- Posted by: Neeraj Pandey
- Category: News
CMP Rs 327.55. Target 2027: Rs 330 (+1%). Target 2028: Rs 365 (+11%). Target 2030: Rs 440 (+34%).
Advanced Enzyme Technologies at Rs 327.55 is a it and technology company whose share price target of Rs 330 for 2027 represents approximately 1 percent upside from the current market price. The Advanced Enzyme Technologies share price target rises to Rs 365 by 2028 and Rs 440 by 2030, implying a 4-year upside of approximately 34 percent from August 2026 levels. Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹15.1 and a fair multiple of approximately20x (moderating to approximately8% growth long-term), the stock’s valuation trend poin.
The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Advanced Enzyme Technologies share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.
Click Here – Get Free Investment Predictions
Advanced Enzyme Technologies Company Overview
| Metric | Details |
|---|---|
| NSE Ticker | ADVENZYMES |
| Sector | IT and Technology |
| CMP (06 Aug 2026) | Rs 327.55 |
| Market Cap | Rs 3666 Cr |
| FY26 EPS | Rs 15.1 (8% annual growth) |
| Advanced Enzyme Technologies Share Price Target 2027 | Rs 330 (+1%) |
| Advanced Enzyme Technologies Share Price Target 2028 | Rs 365 (+11%) |
| Advanced Enzyme Technologies Share Price Target 2030 | Rs 440 (+34%) |
| Bull Case 2030 | Rs 563 |
| Bear Case 2030 | Rs 330 |
What most investors miss: 2nd largest listed integrated enzyme player globally but promoter holding has steadily declined
Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹15. 1 and a fair multiple of approximately20x (moderating to approximately8% growth long-term), the stock’s valuation trend points to the figures above. The share price target of Rs 330 for 2027 and Rs 440 for 2030 reflect this earnings trajectory.
Why Is the Advanced Enzyme Technologies Share Price Target Set at Rs 330 for 2027
Deal Win Momentum and Revenue Visibility
This is the primary driver of the Advanced Enzyme Technologies share price target for 2027 and 2030. Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹15.1 and a fair multiple of approximately20x (moderating to approximately8% growth long-term), the stock’s. Investors tracking this metric quarterly will have the earliest signal of whether the Advanced Enzyme Technologies share price target timeline is on track.
Margin Defense Through Operational Efficiency
The Advanced Enzyme Technologies share price target of Rs 330 for 2027, rising to Rs 440 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Advanced Enzyme Technologies share price target thesis.
AI and Digital Transformation Demand Creates New Revenue
This structural factor underpins the long-term Advanced Enzyme Technologies share price target of Rs 440 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.
Client Diversification and Retention Metrics
For the Advanced Enzyme Technologies share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 365 target in 2028 when earnings quality is most clearly visible.
India’s IT Export Growth Is a Multi-Year Structural Tailwind
India’s long-term economic growth trajectory creates a secular tailwind for Advanced Enzyme Technologies’s business that amplifies the company-specific earnings compounding embedded in the Advanced Enzyme Technologies share price target 2030 of Rs 440 (+34% from CMP Rs 327.55).
Advanced Enzyme Technologies Share Price Targets 2027, 2028 and 2030
Advanced Enzyme Technologies Share Price Target 2027: Rs 330
The Advanced Enzyme Technologies share price target 2027 is Rs 330, representing approximately 1 percent upside from CMP Rs 327.55. Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹15.1 and a fair multiple of approximately20x (moderating to approximately8% growth long-term), the stock’s valuation trend poin. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Advanced Enzyme Technologies share price target.
Advanced Enzyme Technologies Share Price Target 2028: Rs 365
The Advanced Enzyme Technologies share price target 2028 is Rs 365, implying approximately 11 percent upside from CMP. By FY29, Advanced Enzyme Technologies should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Advanced Enzyme Technologies share price target thesis typically triggers institutional re-rating toward the Rs 365 level.
Advanced Enzyme Technologies Share Price Target 2030: Rs 440
The Advanced Enzyme Technologies share price target 2030 is Rs 440, implying approximately 34 percent upside from CMP and a 4-year CAGR of approximately 8 percent. By FY31, Advanced Enzyme Technologies should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.
Bull Case and Bear Case for Advanced Enzyme Technologies Share Price Target 2030
Bull Case: Rs 563
The bull case Advanced Enzyme Technologies share price target of Rs 563 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.
Bear Case: Rs 330
The bear case Advanced Enzyme Technologies share price target of Rs 330 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.
| Scenario | Target 2030 | Return |
|---|---|---|
| Bull Case | Rs 563 | +72% |
| Base Case | Rs 440 | +34% |
| Bear Case | Rs 330 | +1% |
Key Risks to the Advanced Enzyme Technologies Share Price Target
Client Concentration and Deal Renewal Risk
Dependence on a limited number of large clients creates revenue concentration risk that could affect the Advanced Enzyme Technologies share price target.
Currency Fluctuation on USD Revenue
INR appreciation reduces the INR value of Advanced Enzyme Technologies’s foreign currency revenues and compresses the Advanced Enzyme Technologies share price target EPS.
AI Disruption and Automation Reducing Manpower Demand
AI-driven automation could reduce clients’ demand for headcount-intensive IT services, slowing Advanced Enzyme Technologies’s revenue growth and the Advanced Enzyme Technologies share price target.
Talent Retention and Attrition Risk
High attrition or talent scarcity increases delivery costs and reduces margin, compressing the Advanced Enzyme Technologies share price target earnings quality.
How to Invest in Advanced Enzyme Technologies
Use the Univest Screener to track Advanced Enzyme Technologies’s quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker ADVENZYMES. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Advanced Enzyme Technologies share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.
Use the Univest Screener to Track This Stock Live
Conclusion
The Advanced Enzyme Technologies share price target of Rs 330 for 2027, Rs 365 for 2028, and Rs 440 for 2030 reflects analyst consensus earnings compounding in the it and technology sector. The 4-year upside of approximately 34 percent from CMP Rs 327.55 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track Advanced Enzyme Technologies share price live and get daily stock recommendations.
Frequently Asked Questions on Advanced Enzyme Technologies Share Price Target 2027 2028 and 2030
What is the Advanced Enzyme Technologies share price target for 2027?
Ans. The Advanced Enzyme Technologies share price target for 2027 is Rs 330, representing approximately 1 percent upside from CMP Rs 327.55 as of August 2026. Please verify all data at NSE India before investing.
What is the Advanced Enzyme Technologies share price target for 2030?
Ans. The Advanced Enzyme Technologies share price target for 2030 is Rs 440, implying approximately 34 percent upside from CMP Rs 327.55. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.
What is the Advanced Enzyme Technologies share price target for 2028?
Ans. The Advanced Enzyme Technologies share price target for 2028 is Rs 365, implying approximately 11 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.
Is Advanced Enzyme Technologies a good long-term investment?
Ans. Advanced Enzyme Technologies has a defined analyst projection for earnings compounding through FY31 in the it and technology sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.
What are the key risks to the Advanced Enzyme Technologies share price target?
Ans. Key risks include sector-specific headwinds such as client concentration and deal renewal risk, currency fluctuation on usd revenue, and broader macro slowdowns. Please review the full risks section in this article before investing.
What is the bull case for Advanced Enzyme Technologies share price by 2030?
Ans. The bull case Advanced Enzyme Technologies share price target for 2030 is Rs 563, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.
What is Advanced Enzyme Technologies’s current market cap?
Ans. Advanced Enzyme Technologies has a market cap of approximately Rs 3666 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.
How can I invest in Advanced Enzyme Technologies?
Ans. You can buy Advanced Enzyme Technologies shares through any SEBI-registered broker by searching for NSE ticker ADVENZYMES. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.
